End Drug Shortages Act

Hozzl · 2024-12-16T19:26:19Z

Explore the details of House Bill 10239 End Drug Shortages Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

12/16/2024, 7:26 PM

Summary of Bill HR 10239

Bill 118 hr 10239, also known as the Drug Shortage Notification Act, aims to amend the Federal Food, Drug, and Cosmetic Act to address drug shortages caused by sudden increases in demand. The bill requires drug manufacturers to notify the Food and Drug Administration (FDA) of any anticipated shortages or surges in demand for their products.

The purpose of this legislation is to improve transparency and communication between drug manufacturers, the FDA, and healthcare providers in order to better manage and prevent drug shortages. By expanding notification practices to include surges in demand, the bill seeks to ensure that healthcare providers are aware of potential shortages and can take appropriate measures to address them.

Overall, the Drug Shortage Notification Act is designed to help mitigate the impact of drug shortages on patient care and public health by promoting early detection and response to supply disruptions. This legislation is an important step towards ensuring the availability of essential medications for all Americans.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 10239

Bill HR 10239 is currently in the status of Bill Introduced since November 21, 2024. Bill HR 10239 was introduced during Congress 118 and was introduced to the House on November 21, 2024. Bill HR 10239's most recent activity was Referred to the House Committee on Energy and Commerce. as of November 21, 2024

Bipartisan Support of Bill HR 10239

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 10239

Primary Policy Focus

Alternate Title(s) of Bill HR 10239

To amend the Federal Food, Drug, and Cosmetic Act to expand drug shortage notification practices to include surges in demand for a drug, and for other purposes.To amend the Federal Food, Drug, and Cosmetic Act to expand drug shortage notification practices to include surges in demand for a drug, and for other purposes.

Start holding our government accountable!